Quincy Animal Health is a biotechnology company focused on the discovery, development and commercialization of novel compounds to address age-related changes in memory, cognitive performance and related issues of aging pets. The Company’s first product, Neutricks® brand dietary supplement (apoaequorin), is now available for sale by veterinarians. Neutricks® is backed by research that shows it helps support brain health.
Apoaequorin research is conducted with parent company Quincy Bioscience, with academic laboratories, and other research institutions such as CanCog Technologies, a leader in cognitive research. The company’s interests are in metabolism and homeostasis throughout companion animal physiology. Research efforts focus on the effectiveness of apoaequorin, for mild memory problems in aging canines.
Data from the double-blinded placebo testing 'suggest that daily administration of apoaequorin has beneficial effects seen in improved learning, accuracy, and attention.'
Bill Milgram, Ph.D.,